Skip to main content

Chloraseptic Total Sore Throat+Cough Lozenges Disease Interactions

There is 1 disease interaction with Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol topical).

Moderate

Benzocaine (applies to Chloraseptic Total Sore Throat+Cough Lozenges) methemoglobinemia

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: G-6-PD Deficiency

Rarely, benzocaine has induced methemoglobinemia resulting in respiratory distress and cyanosis. Therapy with benzocaine should be administered cautiously to patients with or predisposed to methemoglobinemia. If life-threatening or severe methemoglobinemia develops, methylene blue infused at a dosage of 1 to 2 mg/kg body weight will rapidly reverse or improve the condition except in G-6-PD-deficient patients.

References (2)
  1. (2001) "Product Information. Americaine (benzocaine topical)." Novartis Consumer Health
  2. (2001) "Product Information. Americaine Otic (benzocaine otic)." Medeva Pharmaceuticals

Switch to consumer interaction data

Chloraseptic Total Sore Throat+Cough Lozenges drug interactions

There are 414 drug interactions with Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol topical).

Chloraseptic Total Sore Throat+Cough Lozenges alcohol/food interactions

There is 1 alcohol/food interaction with Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol topical).


Report options

Loading...
QR code containing a link to this page

More about Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol topical)

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.